123 related articles for article (PubMed ID: 6862049)
21. Unexpected reaction of anti-H-2d serum with thymic lymphoma cells derived from transgenic B6-H-2b TCR anti-HY/Db mice.
Matuszyk J; Zioło E; Kobzdej M; Strzadala L
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):103-7. PubMed ID: 8915513
[TBL] [Abstract][Full Text] [Related]
22. Protective antitumor immunity induced by immunization with completely allogeneic tumor cells.
Toes RE; Blom RJ; van der Voort E; Offringa R; Melief CJ; Kast WM
Cancer Res; 1996 Aug; 56(16):3782-7. PubMed ID: 8706024
[TBL] [Abstract][Full Text] [Related]
23. H-2D haplotype-linked expression and involvement of TNF-alpha in Th2 cell-mediated tissue inflammation.
Müller KM; Lisby S; Arrighi JF; Grau GE; Saurat JH; Hauser C
J Immunol; 1994 Jul; 153(1):316-24. PubMed ID: 8207244
[TBL] [Abstract][Full Text] [Related]
24. Strain-dependent variability in immune response to chicken riboflavin carrier protein in mice with different haplotypes.
Subramanian S; Rao J; Jyothi P; Adiga PR
Immunol Invest; 2000 Nov; 29(4):397-409. PubMed ID: 11130782
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
[TBL] [Abstract][Full Text] [Related]
26. Individual mice recognize the complex nature of H-2 antigens; unexpected reactions (anti-Kk) in anti-BALB/c-H-2d sera produced in the BALB/c-H-2db mutant.
Ivanyi P; Melief CJ; de Greeve P; van Mourik P
Transplant Proc; 1979 Mar; 11(1):642-6. PubMed ID: 88092
[No Abstract] [Full Text] [Related]
27. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
Cohen P; Vourka-Karussis U; Weiss L; Slavin S
J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
[TBL] [Abstract][Full Text] [Related]
28. H-2 control of the cytotoxic antibody response against a newly defined MuLV-related cell-surface antigen: G(B10.A).
Vlug A; Zijlstra M; de Goede RE; Hesselink WG; Schoenmakers HJ; Melief CJ
Int J Cancer; 1983 May; 31(5):617-26. PubMed ID: 6303968
[TBL] [Abstract][Full Text] [Related]
29. [Chimeric drift in blood erythrocyte population in BALB/c----C57BL/10 and BALB----B10.D2 mice].
Fedorov LM; Koniukhov BV
Biull Eksp Biol Med; 1988 Sep; 106(9):344-7. PubMed ID: 3048432
[TBL] [Abstract][Full Text] [Related]
30. [Genetic determination of the immune response of mice to cells of various histological types].
Lavrovskiĭ VA; Viksler VKh; Iurchenko IuA; Razvorotnev VA
Genetika; 1978; 14(1):72-80. PubMed ID: 627344
[TBL] [Abstract][Full Text] [Related]
31. One (H-2D2b) of the three Db region-controlled molecules (H-2D1b, H-2D2b, H-2Lb) is not detected in bm13 mutant.
Iványi D; Démant P
J Immunol; 1983 Sep; 131(3):1080-4. PubMed ID: 6604086
[TBL] [Abstract][Full Text] [Related]
32. Frequency of responsiveness to the H-Y antigen among the B10.W lines.
Vucak I; Raska K; Nagy ZA; Klein J
J Immunol; 1983 Jul; 131(1):325-8. PubMed ID: 6863919
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
Lucas CJ; Levy RB; Shearer GM
J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
[TBL] [Abstract][Full Text] [Related]
34. Anti-MHC immunity detected prior to intentional alloimmunization. III. Natural autoreactive H-2-specific antibodies.
Cerný-Provazník R; van Mourik P; Limpens J; Leupers T; Iványi P
Immunogenetics; 1985; 21(5):491-504. PubMed ID: 3873412
[TBL] [Abstract][Full Text] [Related]
35. H-2 typing of RBL-5, TLX/9 tumour cells and L929 fibroblast.
Garrido F; Pérez M; Osorio C
Rev Esp Fisiol; 1978 Jun; 34(2):137-43. PubMed ID: 694200
[TBL] [Abstract][Full Text] [Related]
36. The regulatory functions of Ly-49A, Ly-49D and Ly-49G2 on NK cells in the recognition and rejection of the alloantigen in vivo.
Shimizu I; Tomita Y; Iwai T; Zhang QW; Matsuzaki G; Nomoto K; Yasui H
Transpl Int; 2005 Sep; 18(9):1090-9. PubMed ID: 16104890
[TBL] [Abstract][Full Text] [Related]
37. Mouse sera contain "natural" antibodies directed exclusively against polymorphic--non-histocompatibility--antigens of the chicken Ea- A blood group system.
Plachý J; Spaténková Z; Ríhová B; Boubelík M
Folia Biol (Praha); 1986; 32(2):116-27. PubMed ID: 2424796
[TBL] [Abstract][Full Text] [Related]
38. The histocompatibility-2 system in wild mice. XII. An immunochemical analysis of the anti-Ia antibodies in antisera produced against 13 B10.W lines.
Wakeland EK; Klein J
J Immunol; 1981 May; 126(5):1731-6. PubMed ID: 6938607
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
[TBL] [Abstract][Full Text] [Related]
40. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
